Multiple myeloma and bone

The fatal interaction

Silvia Marino, G. David Roodman

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Multiple myeloma (MM) is the second-most-common hematologic malignancy and the most frequent cancer to involve bone. MM bone disease (MMBD) has devastating consequences for patients, including dramatic bone loss, severe bone pain, and pathological fractures that markedly decrease the quality of life and impact survival ofMMpatients.MMBDresults from excessive osteoclastic bone resorption and persistent suppressed osteoblastic bone formation, causing lytic lesions that do not heal, even when patients are in complete and prolonged remission. This review discusses the cellular and molecular mechanisms that regulate the uncoupling of bone remodeling in MM, the effects of MMBD on tumor growth, and potential therapeutic approaches that may prevent severe bone loss and repair damaged bone in MM patients.

Original languageEnglish (US)
Article numbera031286
JournalCold Spring Harbor perspectives in medicine
Volume8
Issue number8
DOIs
StatePublished - Aug 1 2018

Fingerprint

Multiple Myeloma
Bone
Bone and Bones
Bone Diseases
Spontaneous Fractures
Bone Remodeling
Bone Fractures
Hematologic Neoplasms
Bone Resorption
Osteogenesis
Neoplasms
Quality of Life
Pain
Survival
Growth
Tumors
Repair
Therapeutics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Multiple myeloma and bone : The fatal interaction. / Marino, Silvia; Roodman, G. David.

In: Cold Spring Harbor perspectives in medicine, Vol. 8, No. 8, a031286, 01.08.2018.

Research output: Contribution to journalArticle

@article{0eb7fac2b31740ac9e4e1f926783bfbc,
title = "Multiple myeloma and bone: The fatal interaction",
abstract = "Multiple myeloma (MM) is the second-most-common hematologic malignancy and the most frequent cancer to involve bone. MM bone disease (MMBD) has devastating consequences for patients, including dramatic bone loss, severe bone pain, and pathological fractures that markedly decrease the quality of life and impact survival ofMMpatients.MMBDresults from excessive osteoclastic bone resorption and persistent suppressed osteoblastic bone formation, causing lytic lesions that do not heal, even when patients are in complete and prolonged remission. This review discusses the cellular and molecular mechanisms that regulate the uncoupling of bone remodeling in MM, the effects of MMBD on tumor growth, and potential therapeutic approaches that may prevent severe bone loss and repair damaged bone in MM patients.",
author = "Silvia Marino and Roodman, {G. David}",
year = "2018",
month = "8",
day = "1",
doi = "10.1101/cshperspect.a031286",
language = "English (US)",
volume = "8",
journal = "Cold Spring Harbor perspectives in medicine",
issn = "2157-1422",
publisher = "Cold Spring Harbor Laboratory Press",
number = "8",

}

TY - JOUR

T1 - Multiple myeloma and bone

T2 - The fatal interaction

AU - Marino, Silvia

AU - Roodman, G. David

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Multiple myeloma (MM) is the second-most-common hematologic malignancy and the most frequent cancer to involve bone. MM bone disease (MMBD) has devastating consequences for patients, including dramatic bone loss, severe bone pain, and pathological fractures that markedly decrease the quality of life and impact survival ofMMpatients.MMBDresults from excessive osteoclastic bone resorption and persistent suppressed osteoblastic bone formation, causing lytic lesions that do not heal, even when patients are in complete and prolonged remission. This review discusses the cellular and molecular mechanisms that regulate the uncoupling of bone remodeling in MM, the effects of MMBD on tumor growth, and potential therapeutic approaches that may prevent severe bone loss and repair damaged bone in MM patients.

AB - Multiple myeloma (MM) is the second-most-common hematologic malignancy and the most frequent cancer to involve bone. MM bone disease (MMBD) has devastating consequences for patients, including dramatic bone loss, severe bone pain, and pathological fractures that markedly decrease the quality of life and impact survival ofMMpatients.MMBDresults from excessive osteoclastic bone resorption and persistent suppressed osteoblastic bone formation, causing lytic lesions that do not heal, even when patients are in complete and prolonged remission. This review discusses the cellular and molecular mechanisms that regulate the uncoupling of bone remodeling in MM, the effects of MMBD on tumor growth, and potential therapeutic approaches that may prevent severe bone loss and repair damaged bone in MM patients.

UR - http://www.scopus.com/inward/record.url?scp=85048216408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048216408&partnerID=8YFLogxK

U2 - 10.1101/cshperspect.a031286

DO - 10.1101/cshperspect.a031286

M3 - Article

VL - 8

JO - Cold Spring Harbor perspectives in medicine

JF - Cold Spring Harbor perspectives in medicine

SN - 2157-1422

IS - 8

M1 - a031286

ER -